These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7111359)

  • 21. Variations in activity and inhibition with pH: the protonated amine is the substrate for monoamine oxidase, but uncharged inhibitors bind better.
    Jones TZ; Balsa D; Unzeta M; Ramsay RR
    J Neural Transm (Vienna); 2007; 114(6):707-12. PubMed ID: 17401535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in kinetics of deaminated biogenic amines in spontaneous hypertension].
    Ioffina DI; Smirnov IE; Gorkin VZ
    Vopr Med Khim; 1991; 37(1):59-63. PubMed ID: 1858344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of brain and liver monoamine oxidase in a reptile, Anolis carolinensis.
    Kelley TD; Quay WB
    Comp Gen Pharmacol; 1970 Sep; 1(3):323-35. PubMed ID: 5527568
    [No Abstract]   [Full Text] [Related]  

  • 24. The multiple monoamine oxidases.
    Wyatt RJ
    Adv Biochem Psychopharmacol; 1974; 12(0):1-2. PubMed ID: 4529309
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on monoamine oxidase. (Report XXV). Effects of alcohols on beef liver mitochondrial monoamine oxidase.
    Kurosawa Y
    Jpn J Pharmacol; 1974 Oct; 24(5):787-95. PubMed ID: 4156379
    [No Abstract]   [Full Text] [Related]  

  • 26. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT; Mozayani A; Danielson TJ; Baker GB
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethanol and acetaldehyde effects on metabolism and binding of biogenic amines.
    Lahti RA; Majchrowicz E
    Q J Stud Alcohol; 1974 Mar; 35(1):1-14. PubMed ID: 4151232
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 32. Variations in mitochondrial monoamine oxidase during progressive starvation in the brain of developing rats.
    Ismahan G; Parvez H; Parvez S
    Biochim Biophys Acta; 1979 May; 584(2):196-202. PubMed ID: 435508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine and diamine oxidative deamination in the longitudinal smooth muscle of guinea pig ileum.
    Banchelli G; Raimondi L; Ignesti G; Pirisino R; Buffoni F
    Med Biol; 1985; 63(1):34-9. PubMed ID: 3999819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Brain monoamine oxidase in craniocerebral trauma].
    Akopian AS; Promyslov MSh
    Vopr Med Khim; 1984; 30(1):75-7. PubMed ID: 6710942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of debrisoquin on MAO A and MAO B activities.
    Javors MA; Bembenek ME; Bowden CL; Abell CW; Maas JW
    Life Sci; 1989; 45(24):2359-64. PubMed ID: 2601584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple forms of rat brain monoamine oxidase.
    Youdim MB; Collins GG; Sandler M
    Nature; 1969 Aug; 223(5206):626-8. PubMed ID: 5799536
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of acrylamide on biogenic amine levels, monoamine oxidase, and cathepsin D activity of rat brain.
    Dixit R; Husain R; Mukhtar H; Seth PK
    Environ Res; 1981 Oct; 26(1):168-73. PubMed ID: 7297529
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of fluorostigmine, toxogonin and atropine on monoamine oxidase activity and the level of biogenic amines in mouse brain.
    Kleinrok Z; Jagiełło-Wójtowicz E; Sieklucka-Dziuba M
    Acta Physiol Pol; 1979; 30(4):437-44. PubMed ID: 388982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RS-2232, a compound with a reversible and specific type-A monoamine oxidase inhibiting property in mouse brain.
    Yokoyama T; Iwata N; Kobayashi T
    Jpn J Pharmacol; 1987 Aug; 44(4):421-7. PubMed ID: 3682407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the monoamine oxidase of monkey brain.
    Oommen A; Balasubramanian AS
    J Neurochem; 1977 Mar; 28(3):645-54. PubMed ID: 16088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.